Search - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly

Filter your results

80 Results
authFullName_s : Luc Taillandier

A high 18 F-FDOPA uptake is associated with a slow growth rate in diffuse grade II-III gliomas

Sibel Isal , Guillaume Gauchotte , Fabien Rech , Marie Blonski , Sophie Planel et al.
British Journal of Radiology, 2018, 91 (1084), pp.20170803. ⟨10.1259/bjr.20170803⟩
Journal articles hal-03025124v1
Image document

On the relevance of two manual tumor volume estimation methods for diffuse low-grade gliomas

Meriem Abdallah , Marie Blonski , Sophie Wantz-Mézières , Yann Gaudeau , Luc Taillandier et al.
Healthcare Technology Letters, 2018, 5 (1), pp.13-17. ⟨10.1049/htl.2017.0013⟩
Journal articles hal-01654158v1

Vécu de l’annonce de diagnostic de glioblastome par le patient et son entourage

Rénald Lanfroy , Katia Colmar , Evelyne Garat , Luc Taillandier , Martine Batt et al.
Revue Neurologique, 2012, 168, pp.A72. ⟨10.1016/j.neurol.2012.01.180⟩
Journal articles hal-02408623v1

Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network

Amélie Darlix , Emmanuel Mandonnet , Christian Freyschlag , Daniel Pinggera , Marie-Therese Forster et al.
Neuro-Oncology Practice, 2019, 6 (4), pp.264-273. ⟨10.1093/nop/npy051⟩
Journal articles hal-02567373v1

Un modèle de xénogreffes de gliomes humains et son utilisation en recherches pré-cliniques biologique et thérapeutique

Luc Taillandier
Neurosciences. UHP - Université Henri Poincaré, 2003. Français. ⟨NNT : 2003NAN11309⟩
Theses tel-02020499v1

Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study

Pascale Fabbro-Peray , Sonia Zouaoui , Amelie Darlix , Michel Fabbro , Johan Pallud et al.
Journal of Neuro-Oncology, 2019, 142 (1), pp.91-101. ⟨10.1007/s11060-018-03065-z⟩
Journal articles hal-02593155v1

A Nonradiated Grade II Glioma That Underwent Delayed Malignant Transformation to a Gliosarcoma with Meningeal Growth and Dissemination

Fabien Rech , Valérie Rigau , Michel Fabbro , Christine Kerr , Guillaume Gauchotte et al.
Journal of Neurological Surgery Part A: Central European Neurosurgery, 2014, 75 (06), pp.485-490. ⟨10.1055/s-0034-1372437⟩
Journal articles hal-01687103v1

Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping.

Emmanuel Mandonnet , Saâd Jbabdi , Luc Taillandier , Damien Galanaud , Habib Benali et al.
Neuro-Oncology, 2007, 9 (1), pp.63-9. ⟨10.1215/15228517-2006-015⟩
Journal articles inserm-00164361v1

Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?

Emmanuel Mandonnet , Michel Wager , Fabien Almairac , Marie-Helene Baron , Marie Blonski et al.
Neuro-Oncol.Pract., 2017, 4 (4), pp.241-247. ⟨10.1093/nop/npw031⟩
Journal articles hal-03070609v1
Image document

A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain

Sarah Parisot , Amélie Darlix , Cédric Baumann , Sonia Zouaoui , Yordanka Yordanova et al.
PLoS ONE, 2016, 11 (1), pp.e0144200. ⟨10.1371/journal.pone.0144200⟩
Journal articles hal-01882093v1

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study

Louis Garnier , Chrystelle Vidal , Olivier Chinot , Elisabeth Cohen-Jonathan Moyal , Apolline Djelad et al.
Oncologist, 2022, 27 (5), pp.414-423. ⟨10.1093/oncolo/oyac023⟩
Journal articles hal-03982381v1

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

Helene Lasolle , Christine Cortet , Frederic Castinetti , Lucie Cloix , Philippe Caron et al.
European Journal of Endocrinology, 2017, 176 (6), pp.769-777. ⟨10.1530/EJE-16-0979⟩
Journal articles hal-03555800v1
Image document

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Alice Bonneville-Levard , Didier Frappaz , Olivier Tredan , Emilie Lavergne , Véronique Corset et al.
Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
Journal articles hal-03915456v1

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

Germán Reyes-Botero , Stéphanie Cartalat-Carel , Olivier Chinot , Maryline Barrie , Luc Taillandier et al.
Oncologist, 2018, 23 (5), pp.524-e44. ⟨10.1634/theoncologist.2017-0689⟩
Journal articles hal-01727451v1

Une méthode originale basée sur l’IRM pour évaluer le phénotype infiltrant des gliomes de bas grade

Cyril Brzenczek , Yann Gaudeau , Sophie Wantz-Mézières , Marie Blonski , Fabien Rech et al.
20e Colloque Compression et Représentation des Signaux Audiovisuels, CORESA 2018, Nov 2018, Poitiers, France
Conference papers hal-03024452v1
Image document

Modèles prédictifs pour les gliomes diffus de bas grade sous chimiothérapie

Meriem Ben Abdallah , Marie Blonski , Sophie Wantz-Mézières , Yann Gaudeau , Luc Taillandier et al.
18e Colloque Compression et Représentation des Signaux Audiovisuels, CORESA 2016, May 2016, Nancy, France
Conference papers hal-01316799v1
Image document

Towards a decision-aid tool in the case of chemotherapy treatment for low-grade glioma

Sophie Wantz Mézières , Meriem Ben Abdallah , Marie Blonski , Jean-Marie Moureaux , Yann Gaudeau et al.
17th Annual Conference of the European Network for Business and Industrial Statistics, ENBIS'17, Sep 2017, Naples, Italy
Conference papers hal-02055217v1

Differentiating high-grade glioma progression from treatment-related changes with dynamic [18F]FDOPA PET: a multicentric study

Laura Rozenblum , Timothée Zaragori , Suzanne Tran , Andrea Morales-Martinez , Luc Taillandier et al.
European Radiology, 2023, 33 (4), pp.2548-2560. ⟨10.1007/s00330-022-09221-4⟩
Journal articles hal-03954433v1

La fin de vie (4dernières semaines) de patients pris en charge pour un glioblastome : analyse descriptive, perception des soignants et articulation ville-hôpital.

Guillaume Claudel , Paolo Di Patrizio , Luc Taillandier
Dix-huitième congrès de la SFAP sur le thème « Au-delà des frontières »., Jun 2012, Strasbourg, France
Conference papers hal-03059347v1

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Caroline Houillier , Luc Taillandier , Sylvain Dureau , Thierry Lamy , Mouna Laadhari et al.
Journal of Clinical Oncology, 2019, 37 (10), pp.823+. ⟨10.1200/JCO.18.00306⟩
Journal articles hal-03599523v1

New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach

Hugues Duffau , Luc Taillandier
Neuro-Oncology, 2015, 17 (3), pp.332-42. ⟨10.1093/neuonc/nou153⟩
Journal articles hal-02278504v1

Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery

Guilherme Lucas de Oliveira Lima , Marc Zanello , Emmanuel Mandonnet , Luc Taillandier , Johan Pallud et al.
Neurosurgical Review, 2016, 39 (3), pp.377 - 384. ⟨10.1007/s10143-015-0675-6⟩
Journal articles hal-01885972v1

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

Carole Soussain , Khê Hoang-Xuan , Luc Taillandier , Emmanuelle Fourme , Sylvain Choquet et al.
Journal of Clinical Oncology, 2008, 26 (15), pp.2512-8. ⟨10.1200/JCO.2007.13.5533⟩
Journal articles hal-00452931v1

Correlation of SUV-derived indices with tumoral aggressiveness of gliomas in static 18F-FDOPA PET

Lucile Janvier , Pierre Olivier , Marie Blonski , Olivier Morel , Jean-Michel Vignaud et al.
Clinical Nuclear Medicine, 2015, 40 (9), pp.e429-e435. ⟨10.1097/RLU.0000000000000897⟩
Journal articles hal-01668458v1

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study

Caroline Houillier , Carole Soussain , Hervé Ghesquières , Pierre Soubeyran , Olivier Chinot et al.
Neurology, 2020, 94 (10), pp.e1027-e1039. ⟨10.1212/WNL.0000000000008900⟩
Journal articles hal-02442415v1

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Sophie Langner-Lemercier , Caroline Houillier , Carole Soussain , Hervé Ghesquières , Olivier Chinot et al.
Neuro-Oncology, 2016, 18 (9), pp.1297-1303. ⟨10.1093/neuonc/now033⟩
Journal articles hal-01290413v1

Ki‐67 and MCM6 labelling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1 ‐mutant and 1p/19q‐codeleted: a multicenter study from the French POLA network

Celso Pouget , Sébastien Hergalant , Emilie Lardenois , Stéphanie Lacomme , Rémi Houlgatte et al.
Brain Pathology, 2020, 30 (3), pp.465-478. ⟨10.1111/bpa.12788⟩
Journal articles hal-02299833v1
Image document

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

Louis Garnier , Chrystelle Vidal , Olivier Chinot , Elisabeth Cohen-Jonathan Moyal , Apolline Djelad et al.
Clinical Cancer Research, 2022, 28 (12), pp.2527-2535. ⟨10.1093/oncolo/oyac023⟩
Journal articles hal-03976603v1

Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.

Johan Pallud , Laurent Capelle , Luc Taillandier , Denys Fontaine , Emmanuel Mandonnet et al.
Neuro-Oncology, 2009, 11 (2), pp.176-82. ⟨10.1215/15228517-2008-066⟩
Journal articles inserm-00349509v1

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

Georges Noel , Aymeri Huchet , Loic Feuvret , Jean Philippe Maire , Pierre Verrelle et al.
Journal of Neuro-Oncology, 2012, 109 (1), pp.167-75. ⟨10.1007/s11060-012-0883-7⟩
Journal articles istex hal-00905430v1